Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Butturini

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Nature Communications|August 16, 2020
Genomic characterization of malignant progression in neoplastic pancreatic cystsMichaël Noë, Noushin Niknafs, Catherine G Fischer, et al.
The Lancet Regional Health. Europe|July 17, 2023
Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trialMaarten Korrel, Leia R Jones, Jony van Hilst, et al.
Annals of Surgical Oncology|December 20, 2022
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort StudyEran van Veldhuisen, Sjors Klompmaker, Quisette P Janssen, et al.
Endocrine|January 4, 2024
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national databaseFrancesco Panzuto, Stefano Partelli, Davide Campana, et al.
JAMA Surgery|June 28, 2023
Learning Curves of Minimally Invasive Distal Pancreatectomy in Experienced Pancreatic CentersSanne Lof, Linda Claassen, Gerjon Hannink, et al.
JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
The American Journal of Gastroenterology|October 3, 2023
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic CancerSalvatore Paiella, Gabriele Capurso, Silvia Carrara, et al.
The British Journal of Surgery|July 14, 2022
Benchmarking of minimally invasive distal pancreatectomy with splenectomy: European multicentre studyAlessandro Giani, Tess van Ramshorst, Michele Mazzola, et al.
Annals of Surgery|January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOXIngmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
JAMA Surgery|October 8, 2025
Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA TrialCaro L Bruna, Jony van Hilst, Maarten Korrel, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Nature Communications|August 16, 2020
Genomic characterization of malignant progression in neoplastic pancreatic cystsMichaël Noë, Noushin Niknafs, Catherine G Fischer, et al.
The Lancet Regional Health. Europe|July 17, 2023
Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trialMaarten Korrel, Leia R Jones, Jony van Hilst, et al.
Annals of Surgical Oncology|December 20, 2022
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort StudyEran van Veldhuisen, Sjors Klompmaker, Quisette P Janssen, et al.
Endocrine|January 4, 2024
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national databaseFrancesco Panzuto, Stefano Partelli, Davide Campana, et al.
JAMA Surgery|June 28, 2023
Learning Curves of Minimally Invasive Distal Pancreatectomy in Experienced Pancreatic CentersSanne Lof, Linda Claassen, Gerjon Hannink, et al.
JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
The American Journal of Gastroenterology|October 3, 2023
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic CancerSalvatore Paiella, Gabriele Capurso, Silvia Carrara, et al.
The British Journal of Surgery|July 14, 2022
Benchmarking of minimally invasive distal pancreatectomy with splenectomy: European multicentre studyAlessandro Giani, Tess van Ramshorst, Michele Mazzola, et al.
Annals of Surgery|January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOXIngmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
JAMA Surgery|October 8, 2025
Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA TrialCaro L Bruna, Jony van Hilst, Maarten Korrel, et al.
Pageof 17